Adherencia farmacológica en pacientes sometidos a hemodiálisis en relación a fármacos reguladores del metabolismo óseo-mineral
Fecha
2025
Autores
Perez Calle, Norka Lorena
Asesor
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad Nacional San Luis Gonzaga
Resumen
Analizar en qué medida los pacientes sometidos a hemodiálisis presentan adherencia
farmacológica con relación a los fármacos reguladores del metabolismo óseo-mineral. Estrategia
metodológica. Estudio cuantitativo, diseño no experimental, descriptivo. Población: Usuarios de
la clínica particular de hemodiálisis. Técnica: entrevista. Instrumentos: cuestionario estructurado,
con 2 apartados: datos sociodemográficos y test de adherencia farmacológica SMAQ, y
cuestionario específico de cumplimiento y preferencias de los pacientes sobre fármacos del
metabolismo óseo-renal. Resultados y conclusiones. Se presentan datos generales de los
pacientes hemodializados y datos de los pacientes adherentes. Participación femenina: 53,5%
participación masculina: 46,5%. Edad media de los participantes: 58,25 años. Edad media de los
participantes adherentes: 60,45 años. De manera general, la mayor parte de los pacientes
hemodializados adherentes y no adherentes, tenían menos de un año con tratamiento de
hemodiálisis. Un 52,5% considera que los medicamentos son importantes para evitar problemas
cardiacos, un 20,0% expresó su confianza en el médico al considerar que los medicamentos son
importantes porque lo decía el médico. En utilidad de los medicamentos; el 62,5% considera que
los medicamentos son útiles para evitar problemas cardiacos. Un 22,5% manifiesta utilidad a nivel
del sistema óseo. Un pequeño porcentaje manifestaba no saber la importancia, ni la utilidad de
los medicamentos. El 69,0 % de los pacientes hemodializados, presenta adherencia o
cumplimiento terapéutico con relación al tratamiento farmacológico, complementario al
tratamiento de hemodiálisis.
To analyze the extent to which patients undergoing hemodialysis exhibit pharmacological adherence regarding drugs regulating bone-mineral metabolism. Methodological strategy. Quantitative study, non-experimental design, descriptive. Population: Users of the private hemodialysis clinic. Technique: interview. Instruments: structured questionnaire, with 2 sections: sociodemographic data and pharmacological adherence test SMAQ, and specific questionnaire on compliance and patient preferences regarding drugs for bone-renal metabolism. Results and conclusions. General data of hemodialyzed patients and data of adherent patients are presented. Female participation: 53.5%, male participation: 46.5%. Mean age of participants: 58.25 years. Mean age of adherent participants: 60.45 years. Overall, most adherent, and non-adherent hemodialyzed patients had been on hemodialysis treatment for less than a year. 52.5% consider medications important for avoiding cardiac problems, 20.0% expressed trust in the doctor believing medications are important because the doctor said so. Regarding medication utility, 62.5% consider medications useful for avoiding cardiac problems. 22.5% express utility at the bone system level. A small percentage stated not knowing the importance or utility of medications. 69.0% of hemodialyzed patients exhibit therapeutic adherence or compliance regarding pharmacological treatment, complementary to hemodialysis treatment.
To analyze the extent to which patients undergoing hemodialysis exhibit pharmacological adherence regarding drugs regulating bone-mineral metabolism. Methodological strategy. Quantitative study, non-experimental design, descriptive. Population: Users of the private hemodialysis clinic. Technique: interview. Instruments: structured questionnaire, with 2 sections: sociodemographic data and pharmacological adherence test SMAQ, and specific questionnaire on compliance and patient preferences regarding drugs for bone-renal metabolism. Results and conclusions. General data of hemodialyzed patients and data of adherent patients are presented. Female participation: 53.5%, male participation: 46.5%. Mean age of participants: 58.25 years. Mean age of adherent participants: 60.45 years. Overall, most adherent, and non-adherent hemodialyzed patients had been on hemodialysis treatment for less than a year. 52.5% consider medications important for avoiding cardiac problems, 20.0% expressed trust in the doctor believing medications are important because the doctor said so. Regarding medication utility, 62.5% consider medications useful for avoiding cardiac problems. 22.5% express utility at the bone system level. A small percentage stated not knowing the importance or utility of medications. 69.0% of hemodialyzed patients exhibit therapeutic adherence or compliance regarding pharmacological treatment, complementary to hemodialysis treatment.
Descripción
Palabras clave
Hemodiálisis, Adherencia, Metabolismo, SMAQ